Insilico’s candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. Insilico's candidate has a novel structure that can be synthesized efficiently, designed by its propriety AI-driven small molecule generation platform, Chemistry42.
LEVEL UP!, a new study recently launched by the International Partnership for Queer Youth Resilience (INQYR) and led by researchers at the University of Toronto’s Factor-Inwentash Faculty of Social Work (FIFSW) and Brock University’s Faculty of Education, is examining the possible mental health benefits for LGBTQ+ youth and young adults who play video games.
The Perelman School of Medicine at the University of Pennsylvania has partnered with five historically black colleges and universities for the Penn Access Summer Scholars Program, in an effort to increase the number of physicians from groups underrepresented in medicine.
City of Hope, one of the largest cancer research and treatment organizations in the United States and a national leader in providing cancer patients with best-in-class, integrated supportive care programs, has received a $10 million gift from The Sheri and Les Biller Family Foundation.
- The Sheri and Les Biller Family Foundation
Steven Kachelmeier has been named chair of The University of Texas at Austin McCombs School of Business Department of Accounting, effective Sept. 1.
Quantum Catalyzer (Q-Cat), a new company in the heart of Maryland's research corridor and led by University of Maryland's Dr. Ronald Walsworth, is on a mission to create and grow successful quantum technology start-ups.
The team behind the discovery of Richard III have resumed major archaeological excavations at Leicester Cathedral, close to where the King was found.
- National Lottery Heritage Fund
Imagine this: A smooth touchscreen display placed on top of a thin silicone polymer film suddenly generates the feeling of a tiny raised button under the user's finger. Or how about the idea of wearing that same polymer film like a second skin? If used to line an industrial glove, the film can provide valuable feedback by gesture recognition and by sending tactile signals, such as pulses or vibrations, to the wearer. The research team led by Professor Stefan Seelecke of Saarland University will be at this year’s Hannover Messe, the industrial trade fair running from 30 May to 2 June, where the team will be demonstrating how smart tactile surfaces are now being used as novel human-machine interfaces. Hannover Messe, 30 May to 2 June, Hall 2, Stand B28
24 May 2022 – The Coral Research and Development Accelerator Platform (CORDAP), a G20 initiative, has released a 3-year strategic plan to boost research that aims at helping secure a future for corals and reefs in the face of climate change and other environmental pressures.
The Icahn School of Medicine at Mount Sinai has launched a new research center devoted to understanding how epigenomics influences the nervous system under both healthy and disease conditions. The Center for Neural Epigenome Engineering aims to dramatically expand Mount Sinai’s ability to conduct research in this field, facilitating new discoveries and the development of long-sought treatments for a variety of neurological and psychiatric disorders. Areas of expansion include chromatin biochemistry, chemical biology, protein engineering, and single-cell “omics.”
Penn Medicine and Children’s Hospital of Philadelphia (CHOP), who together pioneered the research and development of the world’s first personalized cellular therapy for cancer — also known as CAR T cell therapy — have announced plans with Costa Rica’s CCSS, or the Caja Costarricense de Seguro Social (Social Security Program), to facilitate CAR T research in Costa Rica. The effort is a step toward global equity in clinical research opportunities involving the use of CAR T cell therapies, which represent a leading-edge approach to cancer care not widely available across the world.